Evidence map›Paper›PMID 42026649›Full record

ArticleCPT: pharmacometrics & systems pharmacology2026

Integration of Time-Varying Pharmacometric Modeling With Cox Regression for Time-to-Event Analysis in NONMEM.

Chih-Wei Lin, Po-Wei Chen, Sameer Doshi, Sandeep Dutta

Abstract read
In one paragraph

Article in CPT: pharmacometrics & systems pharmacology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Chih-Wei LinClinical Pharmacology, Modeling and Simulation, Amgen Inc, Thousand Oaks, California, USA.
Po-Wei ChenClinical Pharmacology, Modeling and Simulation, Amgen Inc, Thousand Oaks, California, USA.
Sameer DoshiClinical Pharmacology, Modeling and Simulation, Amgen Inc, Thousand Oaks, California, USA.
Sandeep DuttaClinical Pharmacology, Modeling and Simulation, Amgen Inc, Thousand Oaks, California, USA.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Although time-varying Cox regression modeling approaches have been developed, exposure-response analyses for time-to-event (TTE) endpoints often rely on static exposure covariates and may overlook the real-world dosing variability and drug concentration fluctuations over time. To better characterize pharmacokinetic (PK) or pharmacodynamic (PD) effects on TTE endpoints, a methodology was proposed to integrate time-varying pharmacometric models with Cox regression in the non-linear mixed effects modeling software, NONMEM. Clinical trial simulations were conducted with different sample sizes and dose levels, employing a one-compartment PK model, a bathtub-shaped function for event hazard, and an I

Indexed as

Models, BiologicalPharmacokineticsComputer SimulationDose-Response Relationship, DrugHumansNonlinear DynamicsProportional Hazards ModelsSoftwareTime Factorscovariatesexposure responseNONMEMPharmacometricssurvival analysis

Identifiers

PMID42026649
PMCPMC13106229

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.